Table 3b:
Concordance between self-reported and clinically ascertained peripheral neuropathy among males (N=1,497)
| Self-Report symptoms | Sensitivity | Specificity | Accuracy | Kappa | |||
|---|---|---|---|---|---|---|---|
| 
 | |||||||
| Clinically ascertained PSN (N=63) | |||||||
| 
 | |||||||
| Yes | No | ||||||
| 
 | |||||||
| Decreased sense of touch or feeling in hands, fingers, arms, or legs, (N) | Yes | 15 | 109 | 24.6% | 92.3% | 89.5% | 0.113 | 
| 
 | |||||||
| No | 46 | 1306 | |||||
| 
 | |||||||
| Prolonged pain in arms, legs, or back, (N) | Yes | 27 | 234 | 44.3% | 83.4% | 81.8% | 0.108 | 
| 
 | |||||||
| No | 34 | 1178 | |||||
| 
 | |||||||
| Abnormal sensation in arms, legs, or back, (N) | Yes | 15 | 125 | 25.4% | 91.1% | 88.5% | 0.100 | 
| 
 | |||||||
| No | 44 | 1286 | |||||
| 
 | |||||||
| ≥2 of 5 symptoms, (N) | Yes | 20 | 157 | 32.8% | 89.0% | 86.7% | 0.114 | 
| 
 | |||||||
| No | 41 | 1270 | |||||
| 
 | |||||||
| Clinically ascertained PMN (N=84) | |||||||
| 
 | |||||||
| Weakness or inability to move arm(s), (N) | Yes | 19 | 31 | 23.8% | 97.8% | 93.8% | 0.261 | 
| 
 | |||||||
| No | 61 | 1361 | |||||
| 
 | |||||||
| Weakness or inability to move legs, (N) | Yes | 28 | 45 | 35.4% | 96.8% | 93.5% | 0.334 | 
| 
 | |||||||
| No | 51 | 1348 | |||||
| 
 | |||||||
| ≥2 of 5 symptoms, (N) | Yes | 40 | 137 | 48.2% | 90.2% | 87.9% | 0.251 | 
| 
 | |||||||
| No | 43 | 1268 | |||||
| 
 | |||||||
| Both PSN and PMN1 (N=23) | |||||||
| 
 | |||||||
| Decreased sense of touch or feeling in hands, fingers, arms, or legs, (N) | Yes | 11 | 113 | 47.8% | 92.2% | 91.5% | 0.127 | 
| 
 | |||||||
| No | 12 | 1340 | |||||
| 
 | |||||||
| Prolonged pain in arms, legs, or back, (N) | Yes | 12 | 249 | 40.0% | 92.3% | 91.8% | 0.058 | 
| 
 | |||||||
| No | 11 | 1201 | |||||
| 
 | |||||||
| Abnormal sensation in arms, legs, or back, (N) | Yes | 9 | 131 | 42.9% | 91.0% | 90.3% | 0.089 | 
| 
 | |||||||
| No | 12 | 1318 | |||||
| 
 | |||||||
| Weakness or inability to move arm(s), (N) | Yes | 7 | 43 | 31.8% | 97.0% | 96.1% | 0.177 | 
| 
 | |||||||
| No | 15 | 1407 | |||||
| 
 | |||||||
| Weakness or inability to move legs, (N) | Yes | 11 | 62 | 52.4% | 95.7% | 95.1% | 0.217 | 
| 
 | |||||||
| No | 10 | 1389 | |||||
| 
 | |||||||
| ≥2 of 5 symptoms, (N) | Yes | 13 | 164 | 56.5% | 88.9% | 88.3% | 0.105 | 
| 
 | |||||||
| No | 10 | 1301 | |||||
| 
 | |||||||
| Either PSN or PMN2 (N=124) | |||||||
| 
 | |||||||
| Decreased sense of touch or feeling in hands, fingers, arms, or legs, (N) | Yes | 38 | 86 | 31.4% | 93.7% | 88.6% | 0.248 | 
| 
 | |||||||
| No | 83 | 1269 | |||||
| 
 | |||||||
| Prolonged pain in arms, legs, or back, (N) | Yes | 55 | 206 | 45.8% | 84.8% | 81.6% | 0.199 | 
| 
 | |||||||
| No | 65 | 1147 | |||||
| 
 | |||||||
| Abnormal sensation in arms, legs, or back, (N) | Yes | 32 | 108 | 27.1% | 92.0% | 86.8% | 0.176 | 
| 
 | |||||||
| No | 86 | 1244 | |||||
| 
 | |||||||
| Weakness or inability to move arm(s), (N) | Yes | 19 | 31 | 16.1% | 97.7% | 91.2% | 0.187 | 
| 
 | |||||||
| No | 99 | 1323 | |||||
| 
 | |||||||
| Weakness or inability to move legs, (N) | Yes | 33 | 40 | 28.2% | 97.0% | 91.6% | 0.305 | 
| 
 | |||||||
| No | 84 | 1315 | |||||
| 
 | |||||||
| ≥2 of 5 symptoms, (N) | Yes | 47 | 130 | 38.8% | 90.5% | 86.3% | 0.242 | 
| 
 | |||||||
| No | 74 | 1237 | |||||
Both PSN and PMN: Individuals with clinically ascertained both PSN and PMN.
Either PSN or PMN: Individuals with clinically ascertained either PSN or PMN.
≥: more than or equal to; %: percent; N: number; PMN: Clinically ascertained peripheral motor neuropathy; PSN: Clinically ascertained peripheral sensory neuropathy